NexGel, Inc. is a provider of healthcare, beauty, and over-the-counter products, including ultra-gentle, high-water-content hydrogels. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. The Company operates through two segments: NexGel and CGN. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CGN segment comprises CG Converting and Packaging, LLC (CGN), a joint venture with C.G. Laboratories Inc. (CG Labs) used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Silly George.
Ticker SymbolNXGL
Company nameNexgel Inc
IPO dateDec 22, 2021
CEOLevy (Adam)
Number of employees19
Security typeOrdinary Share
Fiscal year-endDec 22
Address2150 Cabot Blvd West,
CityLANGHORNE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code19047
Phone12157028550
Websitehttps://nexgel.com/
Ticker SymbolNXGL
IPO dateDec 22, 2021
CEOLevy (Adam)
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data